Bracco Imaging and Subtle Medical obtain CE mark for AI-powered MRI software
Developed through the application of Bracco's imaging and Subtle's software, clinical evidence has demonstrated that AiMIFY provides contrast enhancement for MRI brain scans up to twice the level typically achieved with a labelled dose of gadolinium-based contrast agents (GBCAs).
Consequently, AiMIFY enhances the visualisation of small and poorly enhanced lesions that are critical to the early detection of certain conditions.
US-based Subtle Medical's chief product officer, Ajit Shankaranarayanan, points out that in achieving imaging enhancements in contrast MRI scans, whereby a contrast agent is administered to a patient before an MRI is undertaken, the software requires no adjustments to these standard practices.
According to the companies, validation data for AiMIFY, which was granted software as a medical device (SaMD) clearance from the US Food and Drug Administration (FDA) in October 2024, has demonstrated the technology's efficacy across diverse patient demographics, pathologies, lesion sizes, scanner vendors, MRI sequences, and acquisition orientations.
Radiology platform leader at Bracco Imaging, Sascha Daeuber commented: 'With the CE Mark for AiMIFY, we're taking the next step in our shared mission to deliver innovative, AI-powered solutions that enhance diagnostic precision and support radiologists and patients worldwide."
Bracco and Subtle Medical stated that they will now initiate commercialisation activities for AiMIFY in select European markets, with a phased commercial rollout expected between late 2025 and early 2026.
According to a 2023 report by GlobalData, the use of AI across healthcare is burgeoning, with the market forecast to reach a valuation of around $19bn by 2027. Radiology has emerged as one of the most common areas in which AI is being applied – as a means to drive efficiencies and alleviate clinician burnout.
In a recent report by KPMG on AI's impact on healthcare, 86% of healthcare professionals expressed their belief that AI adoption would give their organisation a competitive edge over those who did not.
"Bracco Imaging and Subtle Medical obtain CE mark for AI-powered MRI software" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
With a new COVID variant on the rise, which US states have the most cases?
Some states are being hit harder than others this summer as a new COVID-19 strain (XGF) continues to spread. Some regions of the U.S. are still experiencing higher rates of positive COVID tests than others, though reporting has slowed down enough nationwide that the Centers for Disease Control (CDC) has begun allowing more time to pass between certain types of updates, such as those on variant prevalence. Testing, cases, hospitalizations and deaths are still being recorded on a weekly basis, however, even amid the chaos of ever-changing strains, recommendations and cuts to vaccine development funding. Here's what to know about the latest data. How many COVID cases were reported nationwide? During the week ending on Aug. 2, 8.5% of the 25,731 Americans tested were positive for COVID, according to the CDC's latest data. This was 2% increase from the week prior. During the same period, only 0.3% of cases resulted in death and 0.9% resulted in an emergency room visit, a 0.1% decrease from the week prior for both categories. More: What is an mRNA vaccine, and why is it controversial? Where are the most COVID cases being reported? See map Western and southern states, including Washington, Oregon, Idaho, California, Nevada, Arizona, New Mexico, Texas, Oklahoma, Arkansas and Louisiana, had higher percentages of positive COVID tests during the week ending Aug. 2. What is the most common COVID variant? The CDC has moved to using longer data timeframes for COVID tracking due to low reporting from states. According to the latest data for the two weeks ending June 21, variant NB.1.8.1 remained the most common, accounting for 43% of cases, followed by LP.8.1 at 31% of cases and XFG at 14%. NB.1.8.1 experienced a meteoric rise to becoming the predominant variant, accounting for 0% of cases in April and only 10% in the last week of May, up to 24% at the beginning of June and 43% by the end. XFG, a combination of variants F.7 and LP.8.1.2, is on the rise as of late, having been responsible for 0% of U.S. cases through March, 11% by early June and 14% by late June. This article originally appeared on USA TODAY: COVID variants, testing and deaths: What to know this week Solve the daily Crossword
Forbes
13 minutes ago
- Forbes
Philippines' Ayala Corp. To Sell Minority Stake In AC Health To Temasek's ABC Impact
AC Health operates a network of pharmacies, clinics and hospitals across the Philippines. Courtesy of Ayala Corp AC Health—a wholly-owned subsidiary of billionaire Jaime Zobel de Ayala and his family 's Ayala Corp.—is selling a 16% stake for an undisclosed amount to ABC Impact, a Singapore-based investor backed by Temasek. In its maiden Philippine venture, ABC Impact will inject primary capital into the healthcare company, supporting the Philippine company's expansion, AC Health said in a statement. ABC Impact has a regional portfolio that includes investments in India, China, and Vietnam. 'ABC Impact's investment reinforces the strength of our integrated model and our commitment to making healthcare more inclusive,' AC Health CEO Paolo Borromeo said. Ayala Corp. said in April it aims to grow AC Health into becoming its next unicorn with $2 billion in equity valuation by 2035, four times its current value. Founded a decade ago, AC Health has been building up its hospitals, multi-specialty clinics, and retail pharmacies through organic growth and acquisitions. By 2027, AC Health aims to expand its network to at least 10 hospitals, 300 clinics, and 1,150 pharmacies. In April, it had 880 drugstores, two drug importers licensed to distribute over 1,178 medicines, 236 corporate and multi-specialty clinics and six hospitals under Healthway Medical. ABC Impact's investment follows a strategic partnership AC Health entered into last week with Dexa Group, one of Indonesia's largest pharmaceutical companies, to import and distribute medicines into the Philippines. Ayala Corp. has invested 15 billion pesos ($263 million) since 2015 into AC Health, which posted a net loss of 610 million in 2024 as asset impairment charges and costs of its new cancer center eroded a 10% increased in sales to 9.4 billion pesos. 'This partnership with Ayala and AC Health reflects our mission to improve lives by advancing access to quality care,' ABC Impact CEO David Heng said. 'Through our regional healthcare experience and impact lens, we aim to support AC Health's efforts to strengthen systems and serve more communities across the Philippines." Ayala Corp., the country's oldest conglomerate, was started by the great grandfather of Jaime Zobel de Ayala , the family patriarch, in 1834 as a distillery. Today, the Manila-listed company has interests in banking, energy, logistics, utilities and real estate. With a net worth of $3.4 billion, the family ranks seventh among the richest in the Philippines.
Yahoo
18 minutes ago
- Yahoo
Nium and iPiD Deepen Strategic Collaboration to Advance VoP Compliance and Global Fraud Prevention
SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- Nium, the leading global infrastructure for real-time cross-border payments, today announced the expansion of Verify, its account validation service, in Europe, through a strengthened strategic partnership with iPiD, the provider of the Know Your Payee (KYP) solution, iPiD Node. As part of this deepening collaboration, iPiD is also leveraging Nium's Verify technology to enhance its own validation capabilities, marking a mutual partnership between two of Singapore's most prominent fintech innovators. By tapping into Nium's established account verification infrastructure, iPiD is able to enhance its global coverage. This two-way partnership underscores both companies' shared vision to increase trust, reduce fraud, and meet evolving regulatory demands in cross-border payments. With VoP becoming a regulatory requirement in the EU by October 2025, payment service providers (PSPs) will be expected not only to verify payee details but also to demonstrate that verification was attempted and properly recorded. Through this collaboration, the integration of iPiD Node extends the reach of Nium's Verify solution in the EU, with audit-ready coverage in the additional 41 countries of the SEPA zone; adding to Nium's instant account verification capabilities in 25 countries globally. Nium's position as the only provider with direct access to global RTP schemes for the purpose of both payments and real-time account validation is complemented by iPiD Node's compliance-ready infrastructure. Since Nium launched Verify, it has helped customers save millions of dollars in fraud and error related costs. A leading global remittance provider saw their error rates reduce from 1.41% to 0.34% after implementing Verify. At the same time, iPiD Node has enabled institutions to meet increasingly stringent VoP compliance requirements through evidence-ready audit logs, while helping reduce false positives and manual reviews in high-risk cross-border transactions. "It's powerful when a trusted partner chooses to become a customer," said Damien Dugauquier, Co-founder & CEO at iPiD. "We're proud to work alongside Nium — not just as fellow Singapore fintechs, but as like-minded teams solving the next generation of cross-border compliance and fraud challenges." While many providers rely solely on name-matching tools for payee validation, Nium's Verify solution, with the integration of the iPiD Node allows its infrastructure to deliver an elevated experience, leveraging real-time API responses directly from domestic RTP systems for unmatched accuracy and fraud prevention, while also providing transparent, accurate and secure cross-border transactions. The addition of iPiD Node also ensures advanced capabilities in the EU including: Real-time request/response name-checking flows Evidence-ready forensics and audit logs to meet regulatory requirements Flexible name-matching logic to balance security with usability "As regulation and risk evolve, we're focused on building infrastructure that goes beyond the payment to provide both compliant and customer-centric solutions," said Alexandra Johnson, Chief Payments Officer at Nium. "Deepening our relationship with iPiD gives us the tools to further scale our Verify solution for account validation with confidence." The collaboration also reflects growing synergy between Singapore's fintech leaders in advancing secure, compliant, and scalable financial infrastructure on the global stage. Together, Nium and iPiD are setting a new standard for payee verification - combining real-time intelligence, regulatory readiness, and ecosystem collaboration to make global payments safer and smarter. About Nium Nium, the leading global infrastructure for real-time cross-border payments, was founded on the mission to deliver the global payments infrastructure of tomorrow, today. With the onset of the global economy, its payments infrastructure is shaping how banks, fintechs, and businesses everywhere collect, convert, and disburse funds instantly across borders. Its payout network supports 100 currencies and spans 190+ countries, 100 of which in real-time. Funds can be disbursed to accounts, wallets, and cards and collected locally in 40 markets. Nium's growing card issuance business is already available in 34 countries. Nium holds regulatory licenses and authorizations in more than 40 countries, enabling seamless onboarding, rapid integration, and compliance – independent of geography. The company is co-headquartered in San Francisco and Singapore. About iPiDiPiD is a global leader in Know Your Payee (KYP) solutions, specializing in payee verification. Our technology enables financial institutions, payments service providers and corporations to improve payment experiences, reduce errors, protect against fraud and ensure compliance. Logo - View original content to download multimedia: SOURCE Nium
